Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Med Lav ; 90(1): 84-7, 1999.
Artículo en Italiano | MEDLINE | ID: mdl-10339956

RESUMEN

The recent classification of a certain number of glass fibres by the European Commission within the framework of the Council Directive 67/548/CEE has reopened the debate on the carcinogenicity of these fibres at the level of the European Union. There is the risk of a law suit being field before the Court of Justice in Luxembourg against Germany, "guilty" of not having observed Community regulations. As regards worker protection, the recent Council Directive on chemical agents reviews the legal aspects concerning both preventive measures and the setting of limit values of occupational exposure.


Asunto(s)
Carcinógenos , Exposición a Riesgos Ambientales , Fibras Minerales/efectos adversos , Neoplasias/etiología , Enfermedades Profesionales/etiología , Exposición Profesional , Contaminantes Ocupacionales del Aire/efectos adversos , Cerámica/efectos adversos , Vidrio , Humanos , Fibras Minerales/normas , Enfermedades Profesionales/prevención & control , Factores de Riesgo , Silicatos/efectos adversos , Factores de Tiempo
5.
Toxicol Lett ; 77(1-3): 191-4, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7618135

RESUMEN

In the European Union, several Council Directives have been adopted which contain measures relating to ambient monitoring and the health surveillance for workers, but only one relates specifically to biological monitoring. Even if the legislative provisions on biological monitoring are limited, the Commission of the European Community has supported activities in this field for several years. In a proposal for a Council Directive on the protection of the health and safety of workers from the risks related to chemical agents at work, which is now under discussion, there are some sentences relating to biological monitoring: (i) where biological monitoring is carried out it shall form part of health surveillance. Where indicated by the nature of the risk, biological monitoring shall be used to reveal pre-clinical effects on the health status of workers in order to permit intervention to prevent clinical deterioration; (ii) the result of biological monitoring shall not be used to discriminate against the worker. Biological limit values and related requirements are to be observed as part of health surveillance.


Asunto(s)
Biomarcadores/análisis , Salud Pública/legislación & jurisprudencia , Unión Europea/organización & administración , Humanos , Salud Laboral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA